hotspot -WSS

hotspot

author：entertainment 2025-09-29 17:02:06 - browse：98

The 7 a.m. Acela out of South Station in Boston trembled along the rails toward Manhattan. David Sabatini sat alone on the left side of the train. He had brought along a science paper to work on, but had a lot on his mind. He kept his Wordle streak alive on his phone, and stared out at the picturesque Connecticut coastline. His clothing hung loose from recent weight loss, presumably from stress.

It was Jan. 4, 2022, a brisk sunny day. The tall, gangling scientist with a long mess of black hair had once generated Nobel Prize buzz for his discoveries in biology. But at that moment, he was unemployed in his 50s, his reputation ruined, spending many nights in his brother’s guest room or on his ex-wife’s sofa, so emotionally distraught that his family was afraid to leave him alone.

Sabatini was journeying to New York in search of a new beginning, an against-all-odds comeback.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： FDA approval of Sarepta Duchenne genetic therapy gives me hope
Next article： In utero gene editing: an explainer

WSS

Departing Stanford president retracts two papers

The Harvard botanist who searched for psychedelics in the Amazon

Alabama frozen embryo ruling has major implications for IVF clinics

Complete sequence of Y chromosome published for first time

In science, is the line between industry and academia shifting?

6 phony surgeries that take placebo to the extreme

hotspot

hotspot

leisure time

Bright Health sells Medicare Advantage business to Molina

Neuroscience startup Neumora files for IPO

23andMe had bad news about my health. I wish a person had delivered it

AstraZeneca bets AAV gene therapy will still deliver the goods

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Antivenom research: Lessons from HIV applied in search for universal antidote

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Annovis Bio delivers candor, but not confidence, on Parkinson’s study

After affirmative action ruling, medical educators look to 'holistic review'

PBM reform efforts get punted in Congress

focus

Apellis safety probe of eye disease drug centers on injection needle

Departing Stanford president retracts two papers

In science, is the line between industry and academia shifting?

Neuroscience startup Neumora files for IPO

Antivenom research: Lessons from HIV applied in search for universal antidote

Apellis safety probe of eye disease drug centers on injection needle

knowledge

hotspot

entertainment

knowledge